Suppr超能文献

中间布鲁氏菌中新型染色体编码氨基糖苷核苷转移酶 ANT(9)-Ic。

ANT(9)-Ic, a Novel Chromosomally Encoded Aminoglycoside Nucleotidyltransferase from Brucella intermedia.

机构信息

Medical Molecular Biology Laboratory, School of Medicine, Jinhua Polytechnic, Jinhua, China.

Institute of Biomedical Informatics, Key Laboratory of Medical Genetics of Zhejiang Province, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.

出版信息

Microbiol Spectr. 2023 Jun 15;11(3):e0062023. doi: 10.1128/spectrum.00620-23. Epub 2023 Apr 11.

Abstract

Aminoglycoside-modifying enzymes are among the most important mechanisms of resistance to aminoglycoside antibiotics, typically conferring high-level resistance by enzymatic drug inactivation. Previously, we isolated a multidrug-resistant Brucella intermedia strain ZJ499 from a cancer patient, and whole-genome sequencing revealed several putative novel aminoglycoside-modifying enzyme genes in this strain. Here, we report the characterization of one of them that encodes an intrinsic, chromosomal aminoglycoside nucleotidyltransferase designated ANT(9)-Ic, which shares only 33.05% to 47.44% amino acid identity with the most closely related ANT(9)-I enzymes. When expressed in Escherichia coli, ANT(9)-Ic conferred resistance only to spectinomycin and not to any other aminoglycosides tested, indicating a substrate profile typical of ANT(9)-I enzymes. Consistent with this, deletion of in ZJ499 resulted in a specific and significant decrease in MIC of spectinomycin. Furthermore, the purified ANT(9)-Ic protein showed stringent substrate specificity for spectinomycin with a value of 44.83 μM and a / of 2.8 × 10 M s, echoing the above observations of susceptibility testing. In addition, comparative genomic analysis revealed that the genetic context of was conserved in Brucella, with no mobile genetic elements found within its 20-kb surrounding region. Overall, our results demonstrate that ANT(9)-Ic is a novel member of the ANT(9)-I lineage, contributing to the intrinsic spectinomycin resistance of ZJ499. The emergence, evolution, and worldwide spread of antibiotic resistance present a significant global public health crisis. For aminoglycoside antibiotics, enzymatic drug modification is the most common mechanism of resistance. We identify a novel chromosomal aminoglycoside nucleotidyltransferase from B. intermedia, called ANT(9)-Ic, which shares the highest identity (47.44%) with the previously known ANT(9)-Ia and plays an important role in spectinomycin resistance of the host strain. Analysis of the genetic environment and origin of shows that the gene and its surrounding region are widely conserved in Brucella, and no mobile elements are detected, indicating that ANT(9)-Ic may be broadly important in the natural resistance to spectinomycin of Brucella species.

摘要

氨基糖苷修饰酶是对抗氨基糖苷类抗生素的最重要机制之一,通常通过酶促药物失活赋予高水平耐药性。先前,我们从一位癌症患者中分离出一株多药耐药布鲁氏菌中间型菌株 ZJ499,全基因组测序显示该菌株中存在几种假定的新型氨基糖苷修饰酶基因。在这里,我们报告了其中一种的特征,该基因编码一种内在的、染色体上的氨基糖苷核苷转移酶,命名为 ANT(9)-Ic,与最密切相关的 ANT(9)-I 酶的氨基酸同一性仅为 33.05%至 47.44%。当在大肠杆菌中表达时,ANT(9)-Ic 仅赋予大观霉素抗性,而不赋予测试的任何其他氨基糖苷类药物抗性,表明其底物谱与 ANT(9)-I 酶典型。与此一致,在 ZJ499 中缺失 导致大观霉素 MIC 特异性且显著降低。此外,纯化的 ANT(9)-Ic 蛋白对大观霉素表现出严格的底物特异性, 值为 44.83μM, / 为 2.8×10 M s,与药敏试验的上述观察结果一致。此外,比较基因组分析表明, 在布鲁氏菌中, 的遗传背景是保守的,在其 20kb 周围区域内没有发现移动遗传元件。总体而言,我们的结果表明 ANT(9)-Ic 是 ANT(9)-I 谱系的新型成员,有助于 ZJ499 对大观霉素的固有耐药性。抗生素耐药性的出现、演变和全球传播构成了重大的全球公共卫生危机。对于氨基糖苷类抗生素,酶促药物修饰是最常见的耐药机制。我们从中间型布鲁氏菌中鉴定出一种新型的染色体氨基糖苷核苷转移酶,称为 ANT(9)-Ic,它与先前已知的 ANT(9)-Ia 具有最高的同源性(47.44%),并在宿主菌株对大观霉素的耐药性中发挥重要作用。对 的遗传环境和来源进行分析表明,该基因及其周围区域在布鲁氏菌中广泛保守,未检测到移动元件,表明 ANT(9)-Ic 可能在布鲁氏菌属对大观霉素的天然耐药性中具有广泛的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5926/10269693/5df3d6f570e4/spectrum.00620-23-f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验